Durvalumab vs Ramipril

## Durvalumab vs Ramipril: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Ramipril**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Ramipril**: Prodrug converted to ramiprilat; ACE inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Ramipril — 13-17 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Ramipril — C23H32N2O5.

**Molecular Weight**: Durvalumab — N/A; Ramipril — 416.5120 g/mol.

**Type**: Durvalumab — Antibody; Ramipril — Small molecule.